Stephen Tong
University of Melbourne, Mercy Hospital for Women, VIC, Australia
- This delegate is presenting an abstract at this event.
 
      
        Professor Stephen Tong is a clinician-scientist (specialist obstetrician) at The Mercy Hospital for Women and The University of Melbourne in Australia. 
He is focussed on translational research. His team has taken 5-6 laboratory concepts to international clinical trials running in United Kingdom, South Africa, New Zealand and across Australia. 
Working with senior researchers, he has led a translational pipeline to identify new drugs to treat preeclampsia. The pipeline begins with laboratory evaluation to discover promising candidates to treat preeclampsia. It extends to successive randomised placebo controlled clinical trials running in South Africa (where the most promising drugs found in the laboratory are evaluated). 
Prof Tong’s also co-leads research programs to develop diagnostics to prevent stillbirth, new treatments for ectopic pregnancy and epidemiology studies evaluating drug safety.
He has published over 190 papers, including contributions over recent years in The Lancet, British Medical Journal, Nature Communication, Human Reproduction Update; and multiple papers in BMC Medicine, Hypertension, American Journal of Obstetrics and Gynaecology; and others. 
He has received three national awards from the National Health and Medical Research Council of Australia. Over the past decade he and his team has obtained over 8 million dollars in competitive grant funding for research.      
      Presentations this author is a contributor to:
                  
          
          The development and evaluation of a placental specific sFlt1 ELISA: a new potential in the prediction and diagnosis of pre-eclampsia. (#253)
  
  5:00 PM
      
    Kirsten R Palmer    
  
          
            
            SRB Poster Session - Pregnancy/Parturition/Placenta          
        
                        
          
          Pravastatin quenches oxysterol-induced upregulation of soluble endoglin in primary endothelial and trophoblast cells: a potential therapeutic for preeclampsia (#30)
  
  10:30 AM
      
    Fiona Brownfoot    
  
          
            
            SRB - ANZPRA Emerging Investigator Award          
        
                        
          
          Nucleic acids coding inflammatory cytokines, and the microbiome are detectable in the circulation of pregnant women with intrauterine infection (#155)
  
  9:15 AM
      
    Owen Stock    
  
          
            
            SRB Orals - Inflammation and the Microbiome          
        
                        
          
          Targeting soluble endoglin to cure preeclampsia (#98)
  
  11:00 AM
      
    Tu'uhevaha Kaitu'u-Lino    
  
          
            
            SRB Symposium 4 - Newcastle Reproductive Science Early Career Researcher Award          
        
            
 ESA-SRB 2013*
                ESA-SRB 2013*